4.6 Article

Towards Personalized Medicine in Myasthenia Gravis: Role of Circulating microRNAs miR-30e-5p, miR-150-5p and miR-21-5p

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Clinical Neurology

Epidemiology, diagnostics, and biomarkers of autoimmune neuromuscular junction disorders

Anna Rostedt Punga et al.

Summary: Autoimmune neuromuscular junction disorders are rare, with myasthenia gravis being increasingly recognized in older individuals. Various diagnostic methods, such as serological antibody, electrophysiological, imaging, and pharmacological tests, are available for these disorders. Determining if the disease is paraneoplastic is important for prognosis. However, objective biomarkers are needed to predict the disease course of myasthenia gravis and Lambert-Eaton myasthenic syndrome.

LANCET NEUROLOGY (2022)

Article Immunology

Prediction and analysis of microRNAs involved in COVID-19 inflammatory processes associated with the NF-kB and JAK/STAT signaling pathways

Zeinab Amini-Farsani et al.

Summary: COVID-19 is a global pandemic with significant morbidity and mortality, and there is currently no approved drug available to eradicate the virus. Research suggests that dysregulation of inflammation pathways may be a key factor in COVID-19 complications, with non-coding RNAs (miRNAs) playing crucial roles in regulating this process.

INTERNATIONAL IMMUNOPHARMACOLOGY (2021)

Article Oncology

Comparison and optimisation of microRNA extraction from the plasma of healthy pregnant women

Victoria L. Parker et al.

Summary: The study compared the performance of two commercially available miRNA extraction kits and found them to be equivalent in terms of miRNA recovery. Optimization attempts did not improve miRNA content, with the Qiagen kit showing slightly better stability. The standard methodology of either kit would be suitable for the investigation of miRNA biomarkers in a healthy pregnant population.

MOLECULAR MEDICINE REPORTS (2021)

Article Immunology

Resolvin D1 Improves the Treg/Th17 Imbalance in Systemic Lupus Erythematosus Through miR-30e-5p

Tao Cheng et al.

Summary: The study showed that RvD1 levels were significantly lower in active SLE patients compared to inactive individuals and controls, which correlated negatively with SLE disease activity. Treatment with RvD1 improved disease phenotype and inflammation in MRL/lpr mice, as well as rebalanced Treg/Th17 differentiation. Moreover, RvD1 was found to increase Treg and decrease Th17 differentiation in vitro, with miR-30e-5p identified as a key downstream microRNA regulating this process.

FRONTIERS IN IMMUNOLOGY (2021)

Article Oncology

Identification and Confirmation of the miR-30 Family as a Potential Central Player in Tobacco-Related Head and Neck Squamous Cell Carcinoma

Tingting Zhang et al.

Summary: The study demonstrated that decreased expression of miR-30e-5p or miR-30b-5p may play a crucial role in the development of cancer, especially tobacco-induced HNSCC, and could serve as a novel candidate biomarker and target for this specific subtype.

FRONTIERS IN ONCOLOGY (2021)

Article Oncology

A novel immune-related ceRNA network that predicts prognosis and immunotherapy response in lung adenocarcinoma

Wei-Jing Gong et al.

Summary: This study explored the association between immune-related lncRNA-miRNA-mRNA-ceRNA networks, and the prognosis of and immunotherapy response in lung adenocarcinoma using RNA-sequencing data from TCGA. The ceRNA network of SNHG6-hsa-miR-30e-5p-CYSLTR1 was identified as being associated with the prognosis of and immunotherapy response in lung adenocarcinoma, providing novel targets for anti-tumor immunotherapy.

ANNALS OF TRANSLATIONAL MEDICINE (2021)

Review Immunology

Muscle-Specific Kinase Myasthenia Gravis

Lucia S. Borges et al.

FRONTIERS IN IMMUNOLOGY (2020)

Review Clinical Neurology

Outcome Measures in Clinical Trials of Patients With Myasthenia Gravis

Jan Lykke Scheel Thomsen et al.

FRONTIERS IN NEUROLOGY (2020)

Article Clinical Neurology

miR-30e-5p as predictor of generalization in ocular myasthenia gravis

Liis Sabre et al.

ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY (2019)

Article Immunology

Chronic inflammatory demyelinating polyneuropathy as an autoimmune disease

Yhojan Rodriguez et al.

JOURNAL OF AUTOIMMUNITY (2019)

Review Cell Biology

Extracellular miRNAs: From Biomarkers to Mediators of Physiology and Disease

Marcelo A. Mori et al.

CELL METABOLISM (2019)

Review Clinical Neurology

Immunotherapy in myasthenia gravis in the era of biologics

Marinos C. Dalakas

NATURE REVIEWS NEUROLOGY (2019)

Article Immunology

Causes and Consequences of miR-150-5p Dysregulation in Myasthenia Gravis

Melanie A. Cron et al.

FRONTIERS IN IMMUNOLOGY (2019)

Article Neurosciences

Silencing miR-150 Ameliorates Experimental Autoimmune Encephalomyelitis

Zhaolan Hu et al.

FRONTIERS IN NEUROSCIENCE (2018)

Article Clinical Neurology

Thymectomy lowers the myasthenia gravis biomarker miR-150-5p

Carl Johan Molin et al.

NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION (2018)

Article Biochemistry & Molecular Biology

Practical data handling pipeline improves performance of qPCR-based circulating miRNA measurements

Maurice W. J. De Ronde et al.

Review Clinical Neurology

Epstein-Barr virus and multiple sclerosis: Updating Pender's hypothesis

Martin Laurence et al.

MULTIPLE SCLEROSIS AND RELATED DISORDERS (2017)

Article Clinical Neurology

Circulating miR-150 in CSF is a novel candidate biomarker for multiple sclerosis

Petra Bergman et al.

NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION (2016)

Article Clinical Neurology

Disease specific signature of circulating miR-150-5p and miR-21-5p in myasthenia gravis patients

Anna Rostedt Punga et al.

JOURNAL OF THE NEUROLOGICAL SCIENCES (2015)

Review Immunology

Myasthenia gravis: A comprehensive review of immune dysregulation and etiological mechanisms

Sonia Berrih-Aknin et al.

JOURNAL OF AUTOIMMUNITY (2014)

Article Clinical Neurology

Circulating miRNAs in myasthenia gravis: miR-150-5p as a new potential biomarker

Tanel Punga et al.

ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY (2014)

Article Clinical Neurology

Circulating MicroRNAs as biomarkers for disease staging in multiple sclerosis

Roopali Gandhi et al.

ANNALS OF NEUROLOGY (2013)

Review Biochemical Research Methods

Assessing sample and miRNA profile quality in serum and plasma or other biofluids

Thorarinn Blondal et al.

METHODS (2013)

Article Medicine, Research & Experimental

Biomarker development for myasthenia gravis

Henry J. Kaminski et al.

MYASTHENIA GRAVIS AND RELATED DISORDERS II (2012)

Review Clinical Neurology

HISTORY OF OUTCOME MEASURES FOR MYASTHENIA GRAVIS

Ted M. Burns

MUSCLE & NERVE (2010)

Review Clinical Neurology

Autoimmune myasthenia gravis: emerging clinical and biological heterogeneity

Matthew N. Meriggioli et al.

LANCET NEUROLOGY (2009)

Review Clinical Neurology

Lifetime course of myasthenia gravis

David Grob et al.

MUSCLE & NERVE (2008)

Article Biochemical Research Methods

Analyzing real-time PCR data by the comparative C-T method

Thomas D. Schmittgen et al.

NATURE PROTOCOLS (2008)